Brief: Baudax Bio Reports Second Quarter 2022 Financial Results And Business Highlights
11/08/2022 12:28
Aug 11 (Reuters) - Baudax Bio Inc BXRX.O :
* BAUDAX BIO REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND
BUSINESS HIGHLIGHTS
* Q2 LOSS PER SHARE $1.05
Source text for Eikon: ID:nGNX2k5fXC
Further company coverage: BXRX.O
Recent news on Baudax Bio
See all newsBrief: Baudax Bio On Feb 22, Filed Voluntary Petition Under Chapter 11 Of U.S. Bankruptcy Code
Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Baudax Bio Says Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024
Brief: Baudax Bio Inc - On October 5, 2023, Board Of Directors Of Company Appointed Natalie Mcandrew As Interim Chief Financial Officer